dacarbazine and Uveitis

dacarbazine has been researched along with Uveitis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amaravadi, RK; Caro, I; Choe, CH; Kempen, JH; McArthur, GA1
Chao, D; de Boer, CJ; Gonzalez, R; Gore, ME; Gutzmer, R; Hait, W; Ho, P; Lang, Z; Lawson, D; Loquai, C; Marshall, D; Mohr, P; O'Day, S; Ottensmeier, C; Pavlick, A; Richards, J; Schadendorf, D; Thompson, JA; Trefzer, U; Uhlar, C; Zhong, B1

Trials

2 trial(s) available for dacarbazine and Uveitis

ArticleYear
Ocular toxicity in BRAF mutant cutaneous melanoma patients treated with vemurafenib.
    American journal of ophthalmology, 2014, Volume: 158, Issue:4

    Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Conjunctivitis; Dacarbazine; Dry Eye Syndromes; Eye Diseases; Female; Humans; Indoles; Male; Melanoma; Middle Aged; Mutation; Neoplasm Staging; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Retrospective Studies; Skin Neoplasms; Sulfonamides; Uveitis; Vemurafenib; Young Adult

2014
A randomised, phase II study of intetumumab, an anti-αv-integrin mAb, alone and with dacarbazine in stage IV melanoma.
    British journal of cancer, 2011, Jul-26, Volume: 105, Issue:3

    Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Disease-Free Survival; Female; Humans; Integrin alphaV; Male; Melanoma; Middle Aged; Skin Neoplasms; Uveitis

2011